ImaginAb's Innovative Biologics Technology Platform Acquired by Telix to Advance Therapeutic Discoveries ImaginAb, Inc. sells its innovative biologics technology platform to Telix Pharmaceuticals Limited, enhancing the discovery of new therapeutic agents.

ImaginAb's Innovative Biologics Technology Platform Acquired by Telix to Advance Therapeutic Discoveries #USA #Telix #ImaginAb #Inglewood #CD8_ImmunoPET

ImaginAb Acquires Innovative Biologics Platform from Telix to Enhance Next-Gen Therapeutics Discovery ImaginAb, Inc. has acquired a groundbreaking biologics platform and pipeline from Telix Pharmaceuticals, focusing on the next generation of therapeutics.

ImaginAb Acquires Innovative Biologics Platform from Telix to Enhance Next-Gen Therapeutics Discovery #USA #Telix #ImaginAb #Inglewood #CD8_ImmunoPET

ImaginAb's Innovative Biologics Technology Acquired by Telix to Enhance Therapeutic Development Telix Pharmaceuticals has acquired ImaginAb's groundbreaking biologics technology platform, focusing on next-gen therapeutic discoveries, particularly in oncology.

ImaginAb's Innovative Biologics Technology Acquired by Telix to Enhance Therapeutic Development #USA #Telix #ImaginAb #Inglewood #CD8_ImmunoPET